Back to Search
ALEXANDRIA IMPERATO, MD
MD
Pulmonary Disease Physician
NPI: 1790282952IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
302755(NY)
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Pulmonary Disease PhysicianPrimary
Internal Medicine — Pulmonary Disease
Code: 207RP1001X
302755(NY)
Education
STATE UNIVERSITY OF NEW YORK AT STONY BROOK, SCHOOL OF MEDICINE
Class of 2018
Research & Publications (13)
Long-term risks associated with biologic response modifiers used in rheumatic diseases.
PMID 15103245·Curr Opin Rheumatol·2004
6-review
Neuroprotective effect of riluzole in a primate model of Parkinson's disease: behavioral and histological evidence.
PMID 11835434·Mov Disord·2002
7-preclinical
Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse.
PMID 11163634·Behav Brain Res·2001
7-preclinical
8-Methylureido-4,5-dihydro-4-oxo-10H-imidazo[1,2-a]indeno[1,2-e]pyrazines: highly potent in vivo AMPA antagonists.
PMID 10741560·Bioorg Med Chem Lett·2000
7-preclinical
4,10-Dihydro-4-oxo-4H-imidazo[1,2-a]indeno[1,2-e]pyrazin-2-carboxylic acid derivatives: highly potent and selective AMPA receptors antagonists with in vivo activity.
PMID 10843235·Bioorg Med Chem Lett·2000
7-preclinical
Indeno[1,2-b]pyrazin-2,3-diones: a new class of antagonists at the glycine site of the NMDA receptor with potent in vivo activity.
PMID 10882363·J Med Chem·2000
7-preclinical
Hemisynaptic distribution patterns of presenilins and beta-APP isoforms in the rodent cerebellum and hippocampus.
PMID 10611635·Synapse·2000
7-preclinical
8-Methylureido-10-amino-10-methyl-imidazo[1,2-a]indeno[1,2-e] pyrazine-4-ones: highly in vivo potent and selective AMPA receptor antagonists.
PMID 11003165·Bioorg Med Chem·2000
7-preclinical
The antioxidant ebselen prevents neurotoxicity and clinical symptoms in a primate model of Parkinson's disease.
PMID 11085889·Exp Neurol·2000
7-preclinical
Riluzole prolongs survival and delays muscle strength deterioration in mice with progressive motor neuronopathy (pmn).
PMID 11090865·J Neurol Sci·2000
7-preclinical
Effects of RPR 118723, a novel antagonist at the glycine site of the NMDA receptor, in vitro.
PMID 10924917·Eur J Pharmacol·2000
7-preclinical
Enhanced long-term potentiation in mice lacking cannabinoid CB1 receptors.
PMID 10619457·Neuroscience·2000
7-preclinical
The protective effect of riluzole in the MPTP model of Parkinson's disease in mice is not due to a decrease in MPP(+) accumulation.
PMID 10727711·Neuropharmacology·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 550 1ST AVE
NEW YORK, NY 10016 - Phone
- (212) 263-5506
Quick Facts
- NPI
- 1790282952
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 8
- Publications
- 13
Are you this provider?
Claim Your Profile